Abstract
Background: We aimed to evaluate the accuracy of home spirometry relative to office spirometry among participants in the PROMISE study, a multicenter, longitudinal, observational study of the clinical effectiveness of elexaftor-tezacaftor-ivacaftor in children (6–11 y/o) and teens/adults (≥12 y/o) with CF (NCT04038047 and NCT04613128).
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Paper Title
Journal
Date
